These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 22461910

  • 1. FOXM1 induces a global methylation signature that mimics the cancer epigenome in head and neck squamous cell carcinoma.
    Teh MT, Gemenetzidis E, Patel D, Tariq R, Nadir A, Bahta AW, Waseem A, Hutchison IL.
    PLoS One; 2012; 7(3):e34329. PubMed ID: 22461910
    [Abstract] [Full Text] [Related]

  • 2. Quantitative study of epigenetic signature in head and neck squamous cell carcinoma.
    Umair A, Tarakji B, Ibrahim A, Nasser A, Fq A, Shreen A.
    Turk J Med Sci; 2015; 45(2):372-86. PubMed ID: 26084130
    [Abstract] [Full Text] [Related]

  • 3. Identification of FOXM1-induced epigenetic markers for head and neck squamous cell carcinomas.
    Hwang S, Mahadevan S, Qadir F, Hutchison IL, Costea DE, Neppelberg E, Liavaag PG, Waseem A, Teh MT.
    Cancer; 2013 Dec 15; 119(24):4249-58. PubMed ID: 24114764
    [Abstract] [Full Text] [Related]

  • 4. FOXM1 upregulation is an early event in human squamous cell carcinoma and it is enhanced by nicotine during malignant transformation.
    Gemenetzidis E, Bose A, Riaz AM, Chaplin T, Young BD, Ali M, Sugden D, Thurlow JK, Cheong SC, Teo SH, Wan H, Waseem A, Parkinson EK, Fortune F, Teh MT.
    PLoS One; 2009 Dec 15; 4(3):e4849. PubMed ID: 19287496
    [Abstract] [Full Text] [Related]

  • 5. Downstream targets of FOXM1: CEP55 and HELLS are cancer progression markers of head and neck squamous cell carcinoma.
    Waseem A, Ali M, Odell EW, Fortune F, Teh MT.
    Oral Oncol; 2010 Jul 15; 46(7):536-42. PubMed ID: 20400365
    [Abstract] [Full Text] [Related]

  • 6. Epigenetic screen of human DNA repair genes identifies aberrant promoter methylation of NEIL1 in head and neck squamous cell carcinoma.
    Chaisaingmongkol J, Popanda O, Warta R, Dyckhoff G, Herpel E, Geiselhart L, Claus R, Lasitschka F, Campos B, Oakes CC, Bermejo JL, Herold-Mende C, Plass C, Schmezer P.
    Oncogene; 2012 Dec 06; 31(49):5108-16. PubMed ID: 22286769
    [Abstract] [Full Text] [Related]

  • 7. LDOC1 silenced by cigarette exposure and involved in oral neoplastic transformation.
    Lee CH, Pan KL, Tang YC, Tsai MH, Cheng AJ, Shen MY, Cheng YM, Huang TT, Lin P.
    Oncotarget; 2015 Sep 22; 6(28):25188-201. PubMed ID: 26317789
    [Abstract] [Full Text] [Related]

  • 8. DNA methylation status of hMLH1, p16(INK4a), and CDH1 is not associated with mRNA expression levels of DNA methyltransferase and DNA demethylase in gastric carcinomas.
    Oue N, Kuraoka K, Kuniyasu H, Yokozaki H, Wakikawa A, Matsusaki K, Yasui W.
    Oncol Rep; 2001 Sep 22; 8(5):1085-9. PubMed ID: 11496321
    [Abstract] [Full Text] [Related]

  • 9. Promoter methylation and loss of p16(INK4a) gene expression in head and neck cancer.
    Demokan S, Chuang A, Suoğlu Y, Ulusan M, Yalnız Z, Califano JA, Dalay N.
    Head Neck; 2012 Oct 22; 34(10):1470-5. PubMed ID: 22106032
    [Abstract] [Full Text] [Related]

  • 10. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
    Koutsimpelas D, Pongsapich W, Heinrich U, Mann S, Mann WJ, Brieger J.
    Oncol Rep; 2012 Apr 22; 27(4):1135-41. PubMed ID: 22246327
    [Abstract] [Full Text] [Related]

  • 11. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.
    Virchows Arch; 2002 Aug 22; 441(2):133-42. PubMed ID: 12189502
    [Abstract] [Full Text] [Related]

  • 12. LKB1 downregulation may be independent of promoter methylation or FOXO3 expression in head and neck cancer.
    Ekizoglu S, Dalay N, Karaman E, Akdeniz D, Ozaydin A, Buyru N.
    Transl Res; 2013 Aug 22; 162(2):122-9. PubMed ID: 23810581
    [Abstract] [Full Text] [Related]

  • 13. The p16 (CDKN2a/INK4a) tumor-suppressor gene in head and neck squamous cell carcinoma: a promoter methylation and protein expression study in 100 cases.
    Ai L, Stephenson KK, Ling W, Zuo C, Mukunyadzi P, Suen JY, Hanna E, Fan CY.
    Mod Pathol; 2003 Sep 22; 16(9):944-50. PubMed ID: 13679459
    [Abstract] [Full Text] [Related]

  • 14. Up-regulation of expression and lack of 5' CpG island hypermethylation of p16 INK4a in HPV-positive cervical carcinomas.
    Ivanova TA, Golovina DA, Zavalishina LE, Volgareva GM, Katargin AN, Andreeva YY, Frank GA, Kisseljov FL, Kisseljova NP.
    BMC Cancer; 2007 Mar 14; 7():47. PubMed ID: 17359536
    [Abstract] [Full Text] [Related]

  • 15. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
    Basu B, Chakraborty J, Chandra A, Katarkar A, Baldevbhai JRK, Dhar Chowdhury D, Ray JG, Chaudhuri K, Chatterjee R.
    Clin Epigenetics; 2017 Mar 14; 9():13. PubMed ID: 28174608
    [Abstract] [Full Text] [Related]

  • 16. The effect of acute dichlorodiphenyltrichloroethane exposure on hypermethylation status and down-regulation of p53 and p16INK4a genes in rat liver.
    Kostka G, Urbanek-Olejnik K, Liszewska M, Winczura A.
    Environ Toxicol; 2016 May 14; 31(5):584-92. PubMed ID: 25410620
    [Abstract] [Full Text] [Related]

  • 17. Dietary folate is associated with p16(INK4A) methylation in head and neck squamous cell carcinoma.
    Kraunz KS, Hsiung D, McClean MD, Liu M, Osanyingbemi J, Nelson HH, Kelsey KT.
    Int J Cancer; 2006 Oct 01; 119(7):1553-7. PubMed ID: 16646054
    [Abstract] [Full Text] [Related]

  • 18. RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells.
    Suzuki M, Sunaga N, Shames DS, Toyooka S, Gazdar AF, Minna JD.
    Cancer Res; 2004 May 01; 64(9):3137-43. PubMed ID: 15126351
    [Abstract] [Full Text] [Related]

  • 19. Hepatitis B virus X protein promotes hypermethylation of p16(INK4A) promoter through upregulation of DNA methyltransferases in hepatocarcinogenesis.
    Zhu YZ, Zhu R, Shi LG, Mao Y, Zheng GJ, Chen Q, Zhu HG.
    Exp Mol Pathol; 2010 Dec 01; 89(3):268-75. PubMed ID: 20620135
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus X protein induces hypermethylation of p16(INK4A) promoter via DNA methyltransferases in the early stage of HBV-associated hepatocarcinogenesis.
    Zhu YZ, Zhu R, Fan J, Pan Q, Li H, Chen Q, Zhu HG.
    J Viral Hepat; 2010 Feb 01; 17(2):98-107. PubMed ID: 19732323
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.